Fenretinide induces autophagic cell death in caspase-defective breast cancer cells
Barbara Fazi1, Wilfried Bursch, Gian Maria Fimia
1Department of Biology, University of Rome Tor Vergata, Rome, Italy.
Abstract:
The elimination of tumor cells by apoptosis is the main mechanism of action of chemotherapeutic drugs. More recently, autophagic cell death has been shown to trigger a nonapoptotic cell death program in cancer cells displaying functional defects of caspases. Fenretinide (FenR), a synthetic derivative of retinoic acid, promotes growth inhibition and induces apoptosis in a wide range of tumor cell types. The present study was designed to evaluate the ability of fenretinide to induce caspase-independent cell death and to this aim we used the human mammary carcinoma cell line MCF-7, lacking functional caspase-3 activity. We demonstrated that in these cells fenretinide is able to trigger an autophagic cell death pathway. In particular we found that fenretinide treatment resulted in the increase in Beclin 1 expression, the conversion of the soluble form of LC3 to the autophagic vesicle-associated form LC3-II and its shift from diffuse to punctate staining and finally the increase in lysosomes/autophagosomes. By contrast, caspase-3 reconstituted MCF-7 cell line showed apoptotic cell death features in response to fenretinide treatment. These data strongly suggest that fenretinide does not invariably elicit an apoptotic response but it is able to induce autophagy when apoptotic pathway is deregulated. The understanding of the molecular mechanisms involved in fenretinide action is important for the future design of therapies employing this retinoid in breast cancer treatment.
Insights
Fenretinide induces autophagic cell death in cancer cells lacking apoptosis mechanisms. This retinoid triggers autophagy by increasing Beclin 1 and LC3-II, offering new therapeutic strategies for breast cancer.
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- Apoptosis is the primary mechanism for chemotherapeutic drugs.
- Autophagic cell death offers a caspase-independent pathway for cancer cell elimination.
- Fenretinide (FenR), a synthetic retinoid, inhibits tumor growth and induces apoptosis.
Purpose of the Study:
- To investigate fenretinide's capacity to induce caspase-independent cell death.
- To explore fenretinide's mechanism of action in cancer cells with defective apoptosis pathways.
Main Methods:
- Utilized the human mammary carcinoma cell line MCF-7, which lacks functional caspase-3.
- Assessed fenretinide's effect on autophagy markers: Beclin 1 expression, LC3-II conversion, and lysosome/autophagosome formation.
- Compared fenretinide's action in caspase-3 reconstituted MCF-7 cells.
Main Results:
- Fenretinide treatment induced autophagic cell death in caspase-3 deficient MCF-7 cells.
- Observed increased Beclin 1 expression and LC3-II conversion, with LC3-II shifting to a punctate pattern.
- Noted an increase in lysosomes and autophagosomes following fenretinide treatment.
- In contrast, fenretinide induced apoptosis in caspase-3 reconstituted cells.
Conclusions:
- Fenretinide's cellular response is context-dependent, inducing autophagy when the apoptotic pathway is impaired.
- This study highlights fenretinide's potential to trigger caspase-independent cell death, suggesting its utility in treating cancers with deregulated apoptosis.
- Understanding these mechanisms is crucial for developing novel retinoid-based breast cancer therapies.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...

